Company signals · Biotech & Pharma
Ratio Therapeutics
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: MitchelLake's Talent Market Index sits at 111.1 (Hot), up 5.2 on the prior month; Americas hiring signal is running rising (+6.3pts).
Ratio Therapeutics: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 24 tracked companies.
Signals at Ratio Therapeutics
More signals across Biotech & Pharma
Partnership · Americas
Basecamp Research →Basecamp Research integrated its EDEN antibiotic and vaccine design models into Claude Science, enabling scientists to design antibiotics and prioritize vaccine targets through Claude's interface.
Partnership · Americas
Bristol Myers Squibb →Bristol Myers Squibb entered into a major alliance with Chinese pharmaceutical firm Hengrui involving up to 13 drugs and valued at up to $15.2 billion. This represents significant international collaboration in drug development and commercialization.
Partnership · Americas
BioDuro →BioDuro forms strategic partnership with CTI Biotechnology to create integrated platform from discovery to IND submission for preclinical drug development
Ma Activity · Americas
Biogen →Biogen announced and closed acquisition of Apellis Pharmaceuticals (immunology and rare diseases) in May 2026, and has just announced a second acquisition of an undisclosed company for $1 billion.
Capital Raising · Americas
BridgeBio →BridgeBio secured funding to support drug launch; United Airlines made an investment into the cell therapy space
Product Launch · Americas
Bota Biosciences →Bota Biosciences released Biology Protocol Language (BPL) and BPL-COGEN, a compiler-verified protocol language and generation pipeline for AI-driven biomanufacturing, announced on bioRxiv.
Intelligence powered by Autonodal ↗